Industry

Vetter Development Services Rankweil is poised for expansion Next milestone for the site development is achieved Positive feedback received from audits with more scheduled Planned expansions will help meet increased customer demand RAVENSBURG, Germany & RANKWEIL, Austria–(BUSINESS WIRE)–With the realization of the first successful customer fills, Vetter, a leading global Contract Development and Manufacturing Organization … [Read more…]

A2a/A2b antagonist candidate, M1069, jointly discovered by Domain Therapeutics and Merck entered into a first-in-human study to investigate the safety, tolerability, PK/PD and clinical activity in patients with metastatic or locally advanced unresectable solid tumors This drug candidate is the first out of Domain’s pipeline to reach clinical development stage in immuno-oncology. STRASBOURG, France & … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Organ-on-a-Chip: Global Markets” report has been added to ResearchAndMarkets.com’s offering. The scope of this report covers various types of products available in the organ-on-a-chip market and potential application sectors in various industries. The organ-on-a-chip market is broken down into various segments. An organ-on-a-chip is a type of artificial organ that possesses the capability … [Read more…]

Zamore brings extensive legal expertise to agilon within the provider and health plan sectors AUSTIN, Texas–(BUSINESS WIRE)–agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced the appointment of Denise Zamore as the company’s first Chief Legal Officer and Secretary to the agilon health Board of Directors … [Read more…]

The partnership will help MMS expand its award-winning services to pharma and biotech companies and extend MMS’ leadership in data-focused clinical research services CANTON, Mich.–(BUSINESS WIRE)–MMS Holdings Inc. (“MMS” or the “Company”), a leading data-focused contract research organization (“CRO”), today announced that Lindsay Goldberg, a leading family and founder-focused private equity firm, has completed an … [Read more…]

ARLINGTON, Va.–(BUSINESS WIRE)–Global nonprofit World Hope International (WHI) has partnered with first-aid supplies and training company My Medic™ to supply 3,000 first aid kits, valued at over $500,000 USD, to emergency first responders who are treating individuals injured as a result of the war in Ukraine. Created by My Medic as an essential trauma kit, … [Read more…]

Company has received Safe to Proceed letters from FDA for two clinical trials in life-threatening brain tumors, DIPG trial is open and actively recruiting, it has expanded its executive leadership team and scientific advisory board and completed a Series B funding round. OAKLAND, Calif.–(BUSINESS WIRE)–#DIPG—SonALAsense, a pioneer in the development of SONALA-001 and sonodynamic therapy … [Read more…]

– Ohio State Wexner Medical Center and Siemens Healthineers have committed to a new strategic relationship to bring the most advanced imaging and treatment technologies from Siemens Healthineers to Ohio State patient care and research centers and the surrounding communities. – The partnership: Provides advanced imaging and cutting-edge radiation oncology modalities at Outpatient Care West … [Read more…]

ANN ARBOR, Mich.–(BUSINESS WIRE)–$NDRA #NAFLD—ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that the United States Patent and Trademark Office has issued a new ENDRA patent, U.S. Patent No. 11369272 (the ‘272 patent) titled “Broadband Applicator for Thermoacoustic Signal Generation.” The ‘272 patent protects TAEUS’ radiofrequency (RF) applicator … [Read more…]

— Combines NewAmsterdam’s lead clinical program obicetrapib with Menarini’s deep cardiovascular disease and regional expertise — — Total deal value of over €1 billion; including €142.5 million upfront payment and committed R&D funding plus potential milestones and double-digit royalties on net product sales in Europe — — Obicetrapib is a next-generation oral, low-dose and once-daily … [Read more…]